[Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
date : 3/9/2022
Tags: NCDs, Precision Cancer Medicine, Survey on Healthcare in Japan
On March 9, 2022, Health and Global Policy Institute (HGPI) released poll data on public opinion about priorities for policies related to cancer genomics and precision medicine.
The new poll, conducted in October over the internet, asked a series of policy-related questions to a group of 1,000 people, selected without exclusion from a monitor panel of a research firm to be representative of the total population of Japan in terms of age, sex, and region.
Research asked participants about their own or family experience with cancer, and about their awareness and understanding of cancer genomics and precision medicine. Most people said that they had no experience with cancer (77.1%), while 10.4% said that someone in their family has had cancer, 3.4% said they themselves have had cancer, 1.5% said that they and someone in their family have had cancer. The remaining 7.6% stated that they preferred not to answer.
In terms of awareness and understanding, 57.2% said that they had never heard of cancer genomics or precision medicine, while 38.6% said they had heard of these treatments but did not know much about them. Just 4.2% said that they felt they were knowledgeable about this topic.
Results related to awareness and understanding were low regardless of cancer history, with an average of only approximately 55% reporting that they have at least heard of cancer genomics or precision medicine.
Respondents were asked about their prior knowledge of the six characteristics of cancer genomics and precision medicine listed below. Regardless of reported understanding about these topics, prior understanding about genomic testing, the timing of testing, and insurance coverage was particularly low. Even among those who reported having high knowledge of cancer genomics and precision medicine (42 respondents), just 9 (21.4%) answered that they knew all of the following points prior to this survey, further suggesting a need for greater awareness raising on this topic.
1. You can’t receive precision medicine at every hospital
2. Genomic tests investigate dozens to hundreds of genomic changes all at once, providing results about the specific characteristics of the patient’s cancer. This allows research into the best treatment for each patient.
3. Only a portion of genomic tests are covered by insurance
4. Genomic tests can only be done at specific time points
5. The probability of a genomic test being able to identify the best treatment for a patient is limited
6. Genomic tests can determine the possibility of a cancer having genomic causes
HGPI will continue to work to raise awareness and advance policy around cancer genomics and precision medicine through its work on non-communicable diseases.
For more information on this project and recent events on it organized by HGPI, please see here.
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)